Home Cart Sign in  
Chemical Structure| 216503-57-0 Chemical Structure| 216503-57-0

Structure of Alemtuzumab
CAS No.: 216503-57-0

Chemical Structure| 216503-57-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Alemtuzumab is a humanized IgG1 monoclonal antibody that targets and depletes B cells and T cells by binding to CD52. Alemtuzumab has potential for multiple sclerosis and chronic lymphocytic leukemia research.

Synonyms: Campath-IH

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Alemtuzumab

CAS No. :216503-57-0
M.W : 146.06 kDa
SMILES Code : NONE
Synonyms :
Campath-IH

Safety of Alemtuzumab

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01395316 Multiple Sclerosis PHASE4 COMPLETED 2025-07-17 -
NCT00336206 B-Cell Chronic Lymphocytic Leu... More >>kemia Less << UNKNOWN 2025-10-09 -
NCT01208337 Evidence of Liver Transplantat... More >>ion|Rejection|ALEMTUZUMAB Less << PHASE2 COMPLETED 2025-11-14 -
NCT00781781 Graft Versus Host Disease PHASE2 TERMINATED 2025-12-11 Hospital Germans Trias i Pujol... More >>, Badalona, Barcelona, 08916, Spain|ICO Bellvitge, Hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Clinic i Provincial., Barcelona, Catalu?a, 08036, Spain|Hospital Clinico de Valencia, Valencia, Comunidad Valenciana, 46010, Spain|Hospital Santa Creu i Sant Pau, Barcelona, 08025, Spain|Vall de Hebron, Barcelona, Spain|Hospital La Princesa, Madrid, 28006, Spain|Hospital Gregorio Mara?on, Madrid, 28007, Spain|Hospital Ramón y Cajal, Madrid, 28034, Spain|Hospital Morales Meseguer, Murcia, 30008, Spain Less <<
NCT01392079 Chronic Lymphocytic Leukemia PHASE2 COMPLETED 2025-03-16 Hanuschkrankenhaus Wien, Wien,... More >> Austria|University Hospital, Wien, Austria|Centre Hospitalier de la C?te Basque, Bayonne, France|Hopital Avicenne, Bobigny Cedex, 93009, France|CHU Estaing, Clermont-Ferrand, France|H?pital Henri Mondor, Creteil -APHP, CRETEIL Cedex, France|CHU de Grenoble, Grenoble, France|CHU Claude Huriez, Lille, France|H?pital Edouard Herriot Lyon, Lyon, France|CHU de Nancy, NANCY Cedex, France|CHU Nantes, Nantes, France|H?pital Pitié Salpêtrière Paris-APHP, Paris, France|H?pital Saint-Louis Paris -APHP, Paris, France|Centre Hospitalier Marechal Joffre H?pital Saint-Jean Perpignan, PERPIGNAN Cedex, France|CHU de Poitiers, POITIERS Cedex, France|CHU Robert-Debre, Reims, 51092, France|CHU de Tours, Tours, France|Charité CBF Berlin, Berlin, Germany|University of Cologne, Cologne, Germany|Dresden Universtiy Hospital, Dresden, Germany|Essen University, Essen, Germany|Freiburg University, Freiburg, Germany|LMU Munich, Grosshadern, Germany|Goettingen University, G?ttingen, Germany|AK St. Georg Hamburg, Hamburg, Germany|Hannover medical school (MHH), Hannover, Germany|Heidelberg University, Heidelberg, Germany|Homburg/Saar University, Homburg/Saar, Germany|Dr. Soeling Kassel, Kassel, Germany|Kiel University, Kiel, Germany|Mainz University, Mainz, Germany|TU Munich, Munich, Germany|Nuernberg University Hospital, Nuernberg, Germany|OncoProGbR Regensburg, Regensburg, Germany|Universtiy of Tuebingen, Tuebingen, Germany|University of ulm, Ulm, 89081, Germany|Dr. Schlag Wuerzburg, Wuerzburg, Germany|University Hospital Wuerzburg, Wuerzburg, Germany Less <<
NCT02419378 Multiple Sclerosis, Relapsing-... More >>Remitting Less << PHASE4 COMPLETED 2025-11-20 Universit?tsklinikum Münster, ... More >>Klinik für Allgemeine Neurologie, Münster, 48149, Germany Less <<
NCT03806387 Multiple Sclerosis COMPLETED 2021-06-30 Aarhus University, Health, Sec... More >>tion for Sport Science, Aarhus, Jutland, 8000, Denmark Less <<
NCT01191749 Leukemia PHASE2 TERMINATED 2025-11-13 UT MD Anderson Cancer Center, ... More >>Houston, Texas, 77030, United States Less <<
NCT00472433 Autoimmune Cytopenias PHASE2 TERMINATED 2025-05-09 Phramongkutklao Hospital, Bang... More >>kok, 10400, Thailand Less <<
NCT01806337 Peripheral T-Cell Lymphoma PHASE2 COMPLETED 2025-02-11 -
NCT05501756 Allogeneic Hematopoietic Cell ... More >>Transplantation Less << PHASE2 RECRUITING 2028-08-31 Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States Less <<
NCT00441025 Peripheral T-Cell Lymphoma PHASE2 TERMINATED 2025-08-09 Siriraj Hospital, Mahidol Univ... More >>ersity, Bangkoknoi, Bangkok, 10700, Thailand Less <<
NCT03135249 Multiple Sclerosis (MS) PHASE4 COMPLETED 2020-11-04 VA North Texas Health Care Sys... More >>tem, Dallas, Texas, 75216, United States|UT Southwestern Medical center, Dallas, Texas, 75390, United States Less <<
NCT06310343 Multiple Sclerosis ACTIVE_NOT_RECRUITING 2025-11-30 Barts Health NHS Trust, London... More >>, Second Floor Neurophys Dept, United Kingdom Less <<
NCT01405807 Vasculitis|Microscopic Polyang... More >>iitis|Granulomatosis With Polyangiitis|Wegener's Less << PHASE4 UNKNOWN 2025-03-14 Addenbrooke's Hospital, Univer... More >>sity of Cambridge NHS Foundation Trust, Cambridge, CB20QQ, United Kingdom Less <<
NCT03250169 Multiple Sclerosis TERMINATED 2022-01-28 Queen Mary University of Londo... More >>n, London, England, E1 2AT, United Kingdom Less <<
NCT01213329 Kidney Transplant PHASE4 TERMINATED 2025-04-09 Northwestern Memorial Hospital... More >>, Chicago, Illinois, 60611, United States Less <<
NCT00637390 Ovarian Cancer|Fallopian Tube ... More >>Cancer|Peritoneal Cancer Less << PHASE1 TERMINATED 2025-10-10 University of Michigan Compreh... More >>ensive Cancer Center, Ann Arbor, Michigan, 48109, United States Less <<
NCT03193086 Multiple Sclerosis UNKNOWN 2020-03-31 Functional Imaging Unit, Depar... More >>tment of Clinical Physiology, Nuclear medicine and PET, Glostrup Hospital, Glostrup, Copenhagen Capital Region, 2600, Denmark Less <<
NCT01333358 Multiple Sclerosis PHASE3 UNKNOWN 2025-03-14 -
NCT03302754 Allogeneic Hematopoietic Cell ... More >>Transplantation Less << COMPLETED 2019-03-10 Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States Less <<
 

Historical Records

Categories